"Die Sophien- und Hufeland-Klinikum gGmbH, Akademisches Lehrkrankenhaus des Universitätsklinikums Jena, erfüllt als modernes Akutkrankenhaus mit über 600 Betten in 16 Fachkliniken regionale und überregionale Versorgungsaufgaben. Pro Jahr nehmen mehr als 23.000 stationäre und rund 39.000 ambulante Patienten das hochwertige Leistungsangebot in Anspruch. Im größten evangelischen Krankenhaus Thüringens bieten über 1.100 qualifizierte Mitarbeitende eine professionelle Unterstützung, seelsorgerische Begleitung und menschliche Zuwendung an. Das Klinikum ist Mitglied im Diakonischen Werk Evangelischer Kirchen in Mitteldeutschland e.V."

During the past decade, Sophien- und Hufeland-Klinikum gGmbH conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sophien- und Hufeland-Klinikum gGmbH" #1 sponsor was "AO Clinical Investigation and Publishing Documentation" with 1 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Center for Sepsis Control and Care, Germany" with 1 trials sponsored, "Leipzig Heart Institute GmbH" with 1 trials sponsored and "University of Giessen" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sophien- und Hufeland-Klinikum gGmbH" #1 collaborator was "Heart Center Leipzig - University Hospital" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Sophien- und Hufeland-Klinikum gGmbH" are "Chronic Heart Failure" (1 trials), "Closed Fracture of Hip" (1 trials), "Hairy Cell Leukemia" (1 trials), "Hip Fractures" (1 trials) and "Osteoporosis in Post-menopausal Women" (1 trials). Many other conditions were trialed in "Sophien- und Hufeland-Klinikum gGmbH" in a lesser frequency.

Most popular intervention types in "Sophien- und Hufeland-Klinikum gGmbH" are "Device" (2 trials), "Drug" (2 trials), "Behavioral" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ASA 100 mg" (1 trials), "CRT-D implantation" (1 trials), "CRT-P implantation" (1 trials), "Change Management" (1 trials) and "Cladribine s.c. injection, HCL treatment" (1 trials). Other intervention names were less common.

The vast majority of trials in "Sophien- und Hufeland-Klinikum gGmbH" are 5 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Sophien- und Hufeland-Klinikum gGmbH". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Sophien- und Hufeland-Klinikum gGmbH, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Sophien- und Hufeland-Klinikum gGmbH, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".